Evercore ISI Cuts Teladoc Health (NYSE:TDOC) Price Target to $14.00

Teladoc Health (NYSE:TDOC) had its price objective trimmed by Evercore ISI from $15.00 to $14.00 in a report published on Friday morning, Benzinga reports. The firm currently has an in-line rating on the health services provider’s stock.

A number of other research firms have also issued reports on TDOC. Canaccord Genuity Group reduced their target price on Teladoc Health from $28.00 to $25.00 and set a buy rating on the stock in a research note on Friday. Cantor Fitzgerald initiated coverage on Teladoc Health in a research note on Thursday, February 29th. They set an overweight rating and a $22.00 price objective on the stock. Leerink Partnrs reissued a market perform rating on shares of Teladoc Health in a research note on Monday, February 26th. Truist Financial decreased their price target on shares of Teladoc Health from $23.00 to $17.00 and set a hold rating on the stock in a research note on Wednesday, March 6th. Finally, Royal Bank of Canada reduced their price objective on shares of Teladoc Health from $30.00 to $25.00 and set an outperform rating on the stock in a research note on Wednesday, February 21st. Twelve research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of Hold and an average price target of $18.73.

Teladoc Health Stock Up 3.0 %

TDOC opened at $13.40 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 3.47 and a current ratio of 3.54. The company has a market cap of $2.27 billion, a price-to-earnings ratio of -9.50 and a beta of 0.94. Teladoc Health has a one year low of $12.65 and a one year high of $30.41. The business’s fifty day moving average is $14.69 and its two-hundred day moving average is $17.67.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Thursday, April 25th. The health services provider reported ($0.49) EPS for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.02). The business had revenue of $646.13 million during the quarter, compared to analyst estimates of $637.31 million. Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.11%. Teladoc Health’s revenue was up 2.7% on a year-over-year basis. During the same period in the previous year, the company posted ($0.37) earnings per share. Analysts anticipate that Teladoc Health will post -1.06 EPS for the current fiscal year.

Insider Buying and Selling

In other Teladoc Health news, EVP Andrew Turitz sold 6,190 shares of the company’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $89,878.80. Following the completion of the sale, the executive vice president now directly owns 39,429 shares in the company, valued at $572,509.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CTO Nikolaos P. Nanis sold 2,866 shares of the firm’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $41,614.32. Following the transaction, the chief technology officer now owns 69,850 shares of the company’s stock, valued at approximately $1,014,222. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Andrew Turitz sold 6,190 shares of the company’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $89,878.80. Following the sale, the executive vice president now directly owns 39,429 shares of the company’s stock, valued at $572,509.08. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 135,441 shares of company stock valued at $2,038,251. 1.63% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of TDOC. ICA Group Wealth Management LLC acquired a new stake in Teladoc Health in the fourth quarter valued at approximately $28,000. Hexagon Capital Partners LLC grew its holdings in Teladoc Health by 204.4% during the 4th quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock valued at $34,000 after purchasing an additional 1,065 shares in the last quarter. RIA Advisory Group LLC purchased a new stake in Teladoc Health during the 4th quarter worth $36,000. GAMMA Investing LLC purchased a new stake in Teladoc Health during the 4th quarter worth $41,000. Finally, Principal Securities Inc. acquired a new position in Teladoc Health in the 4th quarter worth $45,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.